Subscribe to Newsletter

Biochemistry and molecular biology

Diagnostics Cytology

Cracking the Case of Brittle Bones

| Michael Schubert

An excess of osteoclasts is the culprit behind brittle bones in Hajdu-Cheney syndrome.

Diagnostics Microbiology and immunology

Pandemic Protein

| Michael Schubert

The stability of a virus' hemagglutinin protein affects its potential to cause pandemics.

Diagnostics Microbiology and immunology

Predictive Protein

Citrullinated tenascin-C may offer the ability to detect incipient rheumatoid arthritis in a subset of patients as much as 16 years before the onset of disease

Diagnostics Hematology

The Many Faces of Follicular Lymphoma

| German Ott

Follicular lymphoma is currently viewed as a single disease entity – but will recent pathologic findings redefine our perspective?

Diagnostics Profession

An Award-Winning Career

| Fedra Pavlou

Voted Number One on The Pathologist Power List, Manuel Sobrinho-Simões, talks profession, politics, education, innovation, and the ups and the downs of a career that has inspired generations of pathologists.

Diagnostics Oncology

Building a Better Mousetrap

| Michael Schubert

It’s often difficult to target pancreatic cancer cells while sparing healthy tissue – but a new therapy concept not only makes this possible, but also enhances the potential effectiveness of adjuvant treatments

Diagnostics Oncology

An Epigenetic Epiphany

| Michael Schubert

When genetics yielded unsatisfactory answers about pancreatic cancer’s persistent survival, researchers looked beyond the genome – and found telling epigenetic changes

Outside the Lab Oncology

Friend or Foe?

| Anne Marie Lennon

Screening for pancreatic cysts can help with early detection and treatment – but how can we tell which lesions are benign and which may progress to cancer?

Diagnostics Oncology

Surprising Subtypes

| Michael Schubert

Pancreatic cancer is often treated as a homogeneous disease, but new research reveals distinct subtypes of tumor and stromal gene expression

Diagnostics Oncology

New Ab-ilities in Imaging

| Michael Schubert

Pancreatic cancer is a challenge to stage because there’s no good molecular imaging method – but three new antibody conjugates may change that

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register